Skip to main content
Clinical Trials/ITMCTR2200006866
ITMCTR2200006866
Not yet recruiting
未知

Clinical trial on prevention as well as reduction of chemotherapy-induced neuropathy with acupuncture treatment on the breast cancer patients

Jiangsu Provincial Hospital of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Chemotherapy-induced peripheral neuropathy
Sponsor
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Sponsor
Jiangsu Provincial Hospital of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) Patients with histological diagnosis of stage I\-III breast cancer, excluding distant metastases
  • (2\) Patients who plan to receive adjuvant or neoadjuvant chemotherapy (with or without HER\-2 targeted therapy) must be enrolled before the second adjuvant chemotherapy.
  • (3\) Over 18 years of age
  • (4\) Sign informed consent
  • 6\. No serious organic damage to heart, kidney, liver or brain;
  • 7\. Signed the informed consent, participated in and randomly assigned to a study group with no history of substance abuse, and actively cooperated with treatment and follow\-up.

Exclusion Criteria

  • (1\) Previous CIPN\-causing chemotherapy (one dose of chemotherapy allowed).
  • (2\) There were unstable heart disease and myocardial infarction in the first six months
  • (3\) Have a pacemaker or implantable cardioverter defibrillator
  • (4\) Uncontrollable seizures
  • (5\) Prior peripheral neuropathy (PRO\-CTCAE CIPN Scale)
  • (6\) Acupuncture within three months before enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials